Journal of Controlled Release · 2015 · 67 citations · 25 references
PharmacyOncologyPharmacologyCancer PharmacologyOncology PharmacotherapyTargeted Drug DeliveryLiposomal FormulationsLiposome-based DeliveryTargeted Cancer TherapyTargeted TherapyBortezomib TherapyBortezomib-based TherapyNeuroblastoma BiologyRefractory NeuroblastomaTumor Vascular NormalizationTumor Vascular Permeability
25
Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
Alice L. Yu, Andrew L. Gilman, M. Fevzi Özkaynak et al. · New England Journal of Medicine · 2010 · 1.8K citations · Full text
Medicine, Immunology, Oncology +14
E O’Brien, Nely Wigler, Moshe Inbar et al. · Annals of Oncology · 2004 · 1.7K citations · Full text
Medicine, Oncology, Pharmacology +17
Passive versus Active Tumor Targeting Using RGD- and NGR-Modified Polymeric Nanomedicines
Sijumon Kunjachan, Robert Pola, Felix Gremse et al. · Nano Letters · 2014 · 309 citations · Full text
Medicine, Oncology, Pharmacology +17
Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy.
Fabio Pastorino, Chiara Brignole, Danilo Marimpietri et al. · PubMed · 2003 · 297 citations
Medicine, Oncology, Pharmacology +17